Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Soft Tissue Neoplasms | 15 | 2024 | 1166 | 3.620 |
Why?
|
Gastrointestinal Stromal Tumors | 14 | 2022 | 617 | 3.310 |
Why?
|
Sarcoma | 13 | 2022 | 1806 | 2.780 |
Why?
|
Gastrointestinal Neoplasms | 9 | 2023 | 959 | 2.190 |
Why?
|
Nerve Sheath Neoplasms | 4 | 2019 | 170 | 1.610 |
Why?
|
Immunohistochemistry | 26 | 2021 | 11139 | 1.320 |
Why?
|
Chromosome Aberrations | 10 | 2017 | 1781 | 1.300 |
Why?
|
Leiomyosarcoma | 5 | 2021 | 425 | 1.260 |
Why?
|
Neurilemmoma | 4 | 2019 | 524 | 1.230 |
Why?
|
Carcinosarcoma | 3 | 2012 | 108 | 1.110 |
Why?
|
Comparative Genomic Hybridization | 11 | 2017 | 474 | 1.030 |
Why?
|
Receptor, Platelet-Derived Growth Factor alpha | 5 | 2017 | 369 | 1.000 |
Why?
|
Thymus Neoplasms | 3 | 2023 | 278 | 0.920 |
Why?
|
Retinoblastoma Binding Proteins | 2 | 2021 | 102 | 0.850 |
Why?
|
Histones | 4 | 2020 | 2596 | 0.810 |
Why?
|
Chondroblastoma | 2 | 2020 | 47 | 0.780 |
Why?
|
Epithelioid Cells | 2 | 2019 | 60 | 0.750 |
Why?
|
Urachus | 2 | 2012 | 18 | 0.750 |
Why?
|
Neurofibromatosis 1 | 3 | 2015 | 561 | 0.740 |
Why?
|
Heart Neoplasms | 2 | 2023 | 374 | 0.740 |
Why?
|
Rhabdoid Tumor | 2 | 2020 | 210 | 0.700 |
Why?
|
Pheochromocytoma | 4 | 2021 | 328 | 0.700 |
Why?
|
Uterine Neoplasms | 2 | 2021 | 1423 | 0.690 |
Why?
|
Succinate Dehydrogenase | 2 | 2018 | 148 | 0.690 |
Why?
|
Chromosomal Proteins, Non-Histone | 4 | 2020 | 733 | 0.650 |
Why?
|
Severe Acute Respiratory Syndrome | 1 | 2020 | 137 | 0.650 |
Why?
|
Stomach Neoplasms | 4 | 2014 | 1484 | 0.640 |
Why?
|
Genes, p53 | 1 | 2021 | 716 | 0.620 |
Why?
|
Gene Silencing | 3 | 2020 | 1502 | 0.610 |
Why?
|
Pleural Neoplasms | 1 | 2023 | 612 | 0.600 |
Why?
|
Mutation | 14 | 2023 | 30235 | 0.600 |
Why?
|
Bone Neoplasms | 3 | 2020 | 2562 | 0.590 |
Why?
|
Fumarate Hydratase | 1 | 2018 | 55 | 0.580 |
Why?
|
Chloride Channels | 1 | 2018 | 222 | 0.560 |
Why?
|
Giant Cell Tumor of Bone | 1 | 2018 | 119 | 0.560 |
Why?
|
Transcription Factors | 8 | 2023 | 12176 | 0.560 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 2 | 2017 | 711 | 0.550 |
Why?
|
Mesothelioma | 1 | 2023 | 811 | 0.550 |
Why?
|
Fibrosarcoma | 3 | 2024 | 313 | 0.530 |
Why?
|
Vascular Neoplasms | 1 | 2017 | 167 | 0.510 |
Why?
|
Chromosomes, Human, Pair 11 | 2 | 2014 | 410 | 0.500 |
Why?
|
Adrenal Gland Neoplasms | 3 | 2021 | 736 | 0.490 |
Why?
|
In Situ Hybridization, Fluorescence | 8 | 2021 | 2525 | 0.480 |
Why?
|
Liver Neoplasms | 5 | 2023 | 4362 | 0.480 |
Why?
|
Costello Syndrome | 1 | 2014 | 19 | 0.460 |
Why?
|
Oncogene Proteins | 1 | 2018 | 718 | 0.460 |
Why?
|
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2017 | 325 | 0.460 |
Why?
|
Histiocytoma, Malignant Fibrous | 1 | 2014 | 54 | 0.450 |
Why?
|
Ubiquitin-Protein Ligases | 2 | 2021 | 1905 | 0.450 |
Why?
|
X Chromosome Inactivation | 1 | 2016 | 229 | 0.450 |
Why?
|
DNA Mutational Analysis | 11 | 2020 | 4120 | 0.440 |
Why?
|
Methylprednisolone | 2 | 2013 | 387 | 0.440 |
Why?
|
Cystic Duct | 1 | 2012 | 18 | 0.430 |
Why?
|
Rhabdomyosarcoma, Embryonal | 1 | 2014 | 100 | 0.430 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2017 | 614 | 0.410 |
Why?
|
Trisomy | 1 | 2014 | 261 | 0.410 |
Why?
|
Pulmonary Blastoma | 1 | 2012 | 43 | 0.410 |
Why?
|
Splenic Neoplasms | 1 | 2013 | 97 | 0.410 |
Why?
|
Neoplasm Invasiveness | 3 | 2019 | 3637 | 0.410 |
Why?
|
Abdominal Neoplasms | 1 | 2014 | 287 | 0.400 |
Why?
|
Keratosis, Actinic | 1 | 2013 | 73 | 0.390 |
Why?
|
Retroperitoneal Neoplasms | 1 | 2015 | 335 | 0.390 |
Why?
|
Umbilicus | 1 | 2012 | 37 | 0.390 |
Why?
|
Carcinoma, Basosquamous | 1 | 2011 | 7 | 0.380 |
Why?
|
Isocitrate Dehydrogenase | 1 | 2018 | 955 | 0.380 |
Why?
|
Lymphoma, B-Cell, Marginal Zone | 1 | 2013 | 180 | 0.380 |
Why?
|
Neoplasms, Vascular Tissue | 1 | 2011 | 25 | 0.380 |
Why?
|
Intestinal Neoplasms | 2 | 2012 | 317 | 0.380 |
Why?
|
DNA Methylation | 5 | 2017 | 4425 | 0.370 |
Why?
|
Medical Illustration | 1 | 2012 | 135 | 0.370 |
Why?
|
Nuclear Proteins | 4 | 2020 | 5808 | 0.370 |
Why?
|
Carcinoma, Basal Cell | 2 | 2019 | 564 | 0.360 |
Why?
|
Glucose Transporter Type 1 | 1 | 2011 | 186 | 0.360 |
Why?
|
Proto-Oncogene Proteins c-kit | 4 | 2022 | 727 | 0.360 |
Why?
|
Spermatic Cord | 1 | 2010 | 23 | 0.360 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 2 | 2013 | 695 | 0.360 |
Why?
|
Mediastinal Neoplasms | 1 | 2013 | 403 | 0.350 |
Why?
|
Teratoma | 1 | 2013 | 405 | 0.350 |
Why?
|
Humans | 88 | 2024 | 768369 | 0.340 |
Why?
|
Liposarcoma | 3 | 2018 | 289 | 0.340 |
Why?
|
Carcinoma, Signet Ring Cell | 1 | 2010 | 82 | 0.340 |
Why?
|
Gastric Mucosa | 1 | 2012 | 603 | 0.330 |
Why?
|
Carcinoma, Neuroendocrine | 1 | 2013 | 342 | 0.330 |
Why?
|
Paraganglioma | 1 | 2010 | 143 | 0.320 |
Why?
|
Pulmonary Surfactants | 4 | 2012 | 169 | 0.310 |
Why?
|
Choristoma | 1 | 2010 | 205 | 0.310 |
Why?
|
Urination | 1 | 2010 | 203 | 0.310 |
Why?
|
Umbilical Cord | 1 | 2010 | 179 | 0.310 |
Why?
|
Diagnosis, Differential | 9 | 2018 | 13025 | 0.300 |
Why?
|
Arteries | 1 | 2013 | 1126 | 0.290 |
Why?
|
Ileum | 1 | 2010 | 558 | 0.290 |
Why?
|
Capillaries | 1 | 2011 | 756 | 0.290 |
Why?
|
DNA Helicases | 3 | 2020 | 853 | 0.280 |
Why?
|
Neoplasm Recurrence, Local | 7 | 2024 | 9425 | 0.280 |
Why?
|
Middle Aged | 44 | 2024 | 223406 | 0.280 |
Why?
|
Bile Duct Neoplasms | 1 | 2012 | 617 | 0.280 |
Why?
|
Male | 55 | 2024 | 364761 | 0.280 |
Why?
|
Suture Techniques | 1 | 2012 | 776 | 0.280 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 2 | 2014 | 1766 | 0.270 |
Why?
|
Tumor Burden | 4 | 2018 | 1909 | 0.270 |
Why?
|
Spleen | 1 | 2013 | 2298 | 0.270 |
Why?
|
Edema | 2 | 2010 | 766 | 0.270 |
Why?
|
Antineoplastic Agents | 3 | 2022 | 13709 | 0.270 |
Why?
|
Cyclin-Dependent Kinase 4 | 3 | 2022 | 564 | 0.260 |
Why?
|
Stomach | 1 | 2010 | 703 | 0.260 |
Why?
|
Female | 45 | 2024 | 396926 | 0.250 |
Why?
|
Vascular Malformations | 1 | 2011 | 469 | 0.250 |
Why?
|
Lipoma | 2 | 2018 | 296 | 0.250 |
Why?
|
Lung Neoplasms | 3 | 2023 | 13589 | 0.250 |
Why?
|
Adenoma | 2 | 2013 | 2163 | 0.250 |
Why?
|
Carcinoma | 1 | 2017 | 2341 | 0.250 |
Why?
|
Testicular Neoplasms | 1 | 2010 | 806 | 0.230 |
Why?
|
Aged | 27 | 2024 | 171514 | 0.220 |
Why?
|
Heredity | 2 | 2014 | 148 | 0.220 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2012 | 2847 | 0.210 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3116 | 0.200 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3240 | 0.200 |
Why?
|
Cyclin-Dependent Kinase 2 | 1 | 2022 | 184 | 0.200 |
Why?
|
Cell Proliferation | 2 | 2018 | 10490 | 0.200 |
Why?
|
Angiomyolipoma | 1 | 2023 | 188 | 0.200 |
Why?
|
Metanephrine | 1 | 2021 | 25 | 0.190 |
Why?
|
Oncogene Proteins, Fusion | 3 | 2020 | 1614 | 0.190 |
Why?
|
Neoplasms | 2 | 2023 | 22389 | 0.190 |
Why?
|
Young Adult | 16 | 2024 | 60038 | 0.190 |
Why?
|
Gene Rearrangement | 2 | 2018 | 1139 | 0.190 |
Why?
|
Tumor Suppressor Protein p53 | 3 | 2017 | 2964 | 0.180 |
Why?
|
Genes, p16 | 1 | 2021 | 160 | 0.180 |
Why?
|
Esophageal Neoplasms | 1 | 2011 | 1676 | 0.180 |
Why?
|
Biopsy | 6 | 2018 | 6816 | 0.180 |
Why?
|
Tropomyosin | 1 | 2020 | 106 | 0.170 |
Why?
|
Maxillary Neoplasms | 1 | 2020 | 47 | 0.170 |
Why?
|
Odontogenic Cysts | 1 | 2020 | 42 | 0.170 |
Why?
|
Adult | 27 | 2024 | 223528 | 0.170 |
Why?
|
Dioxygenases | 1 | 2022 | 351 | 0.170 |
Why?
|
Necrosis | 2 | 2017 | 1622 | 0.170 |
Why?
|
Ubiquitin Thiolesterase | 1 | 2023 | 467 | 0.170 |
Why?
|
Ovarian Neoplasms | 1 | 2017 | 4906 | 0.170 |
Why?
|
Melanoma | 2 | 2015 | 5740 | 0.170 |
Why?
|
Sucrose | 1 | 2020 | 159 | 0.170 |
Why?
|
Odontogenic Tumors | 1 | 2020 | 48 | 0.170 |
Why?
|
Cyclin-Dependent Kinase 6 | 1 | 2022 | 352 | 0.170 |
Why?
|
Takotsubo Cardiomyopathy | 1 | 2021 | 125 | 0.160 |
Why?
|
Reperfusion Injury | 3 | 2012 | 1034 | 0.160 |
Why?
|
Mandibular Neoplasms | 1 | 2020 | 131 | 0.160 |
Why?
|
Prognosis | 9 | 2018 | 30031 | 0.160 |
Why?
|
DNA-Binding Proteins | 5 | 2022 | 9623 | 0.160 |
Why?
|
Carcinoma, Squamous Cell | 2 | 2011 | 4083 | 0.150 |
Why?
|
Pulmonary Edema | 1 | 2021 | 409 | 0.150 |
Why?
|
High-Throughput Nucleotide Sequencing | 3 | 2020 | 3669 | 0.150 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2010 | 2254 | 0.150 |
Why?
|
Histoplasmosis | 1 | 2018 | 63 | 0.150 |
Why?
|
Technology | 1 | 2020 | 296 | 0.150 |
Why?
|
Molecular Biology | 1 | 2021 | 573 | 0.140 |
Why?
|
Sensitivity and Specificity | 3 | 2017 | 14725 | 0.140 |
Why?
|
Antigens, CD34 | 2 | 2017 | 656 | 0.140 |
Why?
|
Myoma | 1 | 2017 | 6 | 0.140 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p18 | 1 | 2017 | 53 | 0.140 |
Why?
|
Succinic Acid | 1 | 2018 | 86 | 0.140 |
Why?
|
Lung | 5 | 2021 | 10090 | 0.140 |
Why?
|
Fumarates | 1 | 2018 | 132 | 0.140 |
Why?
|
Respiratory System | 1 | 2020 | 565 | 0.140 |
Why?
|
Mixed Function Oxygenases | 1 | 2018 | 265 | 0.140 |
Why?
|
HMGA2 Protein | 1 | 2017 | 101 | 0.130 |
Why?
|
Hypertension | 4 | 2021 | 8610 | 0.130 |
Why?
|
Autopsy | 1 | 2020 | 1013 | 0.130 |
Why?
|
Chromosomes, Human, Pair 14 | 1 | 2017 | 286 | 0.130 |
Why?
|
Fatal Outcome | 3 | 2021 | 1841 | 0.130 |
Why?
|
Glutarates | 1 | 2018 | 243 | 0.130 |
Why?
|
Pedigree | 2 | 2014 | 4545 | 0.130 |
Why?
|
World Health Organization | 1 | 2022 | 1327 | 0.130 |
Why?
|
Aged, 80 and over | 12 | 2024 | 59679 | 0.130 |
Why?
|
Solitary Fibrous Tumors | 1 | 2016 | 70 | 0.130 |
Why?
|
Infarction | 1 | 2017 | 249 | 0.130 |
Why?
|
Neurofibromin 1 | 1 | 2017 | 190 | 0.130 |
Why?
|
Thymoma | 1 | 2017 | 191 | 0.120 |
Why?
|
Gout | 1 | 2022 | 621 | 0.120 |
Why?
|
PTEN Phosphohydrolase | 1 | 2021 | 1119 | 0.120 |
Why?
|
Neoplasms, Muscle Tissue | 1 | 2015 | 67 | 0.120 |
Why?
|
Adolescent | 12 | 2024 | 89163 | 0.120 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 2 | 2018 | 369 | 0.120 |
Why?
|
Desmin | 1 | 2014 | 99 | 0.120 |
Why?
|
Child, Preschool | 5 | 2024 | 42620 | 0.110 |
Why?
|
Paraganglioma, Extra-Adrenal | 1 | 2014 | 47 | 0.110 |
Why?
|
Chondroma | 1 | 2014 | 53 | 0.110 |
Why?
|
Germany | 2 | 2015 | 882 | 0.110 |
Why?
|
Hutchinson's Melanotic Freckle | 1 | 2013 | 26 | 0.110 |
Why?
|
Mechanoreceptors | 1 | 2015 | 194 | 0.110 |
Why?
|
Mycetoma | 1 | 2013 | 18 | 0.110 |
Why?
|
Lung Abscess | 1 | 2013 | 40 | 0.110 |
Why?
|
Proto-Oncogene Proteins | 2 | 2018 | 4534 | 0.110 |
Why?
|
Intestinal Polyps | 1 | 2014 | 105 | 0.110 |
Why?
|
Genes, Neurofibromatosis 1 | 1 | 2013 | 74 | 0.110 |
Why?
|
Arthroplasty, Replacement, Knee | 2 | 2021 | 1401 | 0.110 |
Why?
|
Leukemia, B-Cell | 1 | 2013 | 86 | 0.110 |
Why?
|
Antibodies, Monoclonal | 3 | 2018 | 9261 | 0.110 |
Why?
|
Hyalin | 1 | 2013 | 35 | 0.110 |
Why?
|
Pulmonary Aspergillosis | 1 | 2013 | 48 | 0.110 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2020 | 4582 | 0.110 |
Why?
|
Calmodulin-Binding Proteins | 1 | 2014 | 239 | 0.100 |
Why?
|
Biopsy, Fine-Needle | 1 | 2018 | 1131 | 0.100 |
Why?
|
Cystadenoma | 1 | 2013 | 79 | 0.100 |
Why?
|
Receptors, Estrogen | 1 | 2021 | 2243 | 0.100 |
Why?
|
RNA-Binding Protein EWS | 1 | 2014 | 211 | 0.100 |
Why?
|
Adenocarcinoma | 1 | 2010 | 6400 | 0.100 |
Why?
|
Osteopontin | 1 | 2014 | 308 | 0.100 |
Why?
|
Digestive System Surgical Procedures | 2 | 2015 | 584 | 0.100 |
Why?
|
Cell Shape | 1 | 2013 | 371 | 0.100 |
Why?
|
Brain Neoplasms | 2 | 2011 | 9177 | 0.100 |
Why?
|
Chromosome Deletion | 1 | 2017 | 1390 | 0.100 |
Why?
|
Genetic Predisposition to Disease | 5 | 2020 | 18047 | 0.100 |
Why?
|
Phenotype | 4 | 2020 | 16712 | 0.100 |
Why?
|
Parotid Gland | 1 | 2013 | 178 | 0.100 |
Why?
|
Blood-Air Barrier | 2 | 2012 | 24 | 0.100 |
Why?
|
Neoplasm, Residual | 1 | 2017 | 1014 | 0.100 |
Why?
|
Time Factors | 4 | 2024 | 40271 | 0.100 |
Why?
|
Radiation Injuries, Experimental | 1 | 2011 | 89 | 0.100 |
Why?
|
Treatment Outcome | 8 | 2024 | 65408 | 0.100 |
Why?
|
Disease-Free Survival | 3 | 2017 | 6856 | 0.090 |
Why?
|
Temporal Arteries | 1 | 2013 | 155 | 0.090 |
Why?
|
Organ Preservation Solutions | 1 | 2012 | 100 | 0.090 |
Why?
|
Kaplan-Meier Estimate | 3 | 2017 | 6537 | 0.090 |
Why?
|
Splenectomy | 1 | 2013 | 392 | 0.090 |
Why?
|
Telomerase | 1 | 2016 | 749 | 0.090 |
Why?
|
Parotid Neoplasms | 1 | 2013 | 158 | 0.090 |
Why?
|
Pinealoma | 1 | 2011 | 52 | 0.090 |
Why?
|
Heart Arrest | 1 | 2021 | 1516 | 0.090 |
Why?
|
Cholecystolithiasis | 1 | 2010 | 7 | 0.090 |
Why?
|
Primary Graft Dysfunction | 1 | 2012 | 112 | 0.090 |
Why?
|
Diverticulosis, Colonic | 1 | 2010 | 9 | 0.090 |
Why?
|
Opportunistic Infections | 1 | 2013 | 376 | 0.090 |
Why?
|
Hemangioendothelioma | 1 | 2011 | 112 | 0.090 |
Why?
|
Leiomyoma | 1 | 2015 | 641 | 0.090 |
Why?
|
Chromosomes, Human, Pair 7 | 1 | 2011 | 310 | 0.090 |
Why?
|
Pineal Gland | 1 | 2011 | 158 | 0.090 |
Why?
|
Oligonucleotide Array Sequence Analysis | 3 | 2017 | 3793 | 0.090 |
Why?
|
Thigh | 1 | 2011 | 239 | 0.090 |
Why?
|
Mitosis | 1 | 2015 | 1191 | 0.090 |
Why?
|
Aneurysm, False | 1 | 2013 | 264 | 0.090 |
Why?
|
Chromosomes, Human, Pair 2 | 1 | 2011 | 313 | 0.090 |
Why?
|
Predictive Value of Tests | 4 | 2018 | 15459 | 0.090 |
Why?
|
Follow-Up Studies | 5 | 2018 | 39429 | 0.080 |
Why?
|
Fibrosis | 1 | 2017 | 2076 | 0.080 |
Why?
|
Connective Tissue | 2 | 2022 | 425 | 0.080 |
Why?
|
Cryptorchidism | 1 | 2010 | 152 | 0.080 |
Why?
|
Mucin-1 | 1 | 2014 | 538 | 0.080 |
Why?
|
Chromosomal Instability | 1 | 2010 | 178 | 0.080 |
Why?
|
Anti-Inflammatory Agents | 2 | 2010 | 1816 | 0.080 |
Why?
|
Neoplasms, Unknown Primary | 1 | 2010 | 101 | 0.080 |
Why?
|
Pseudomonas Infections | 1 | 2013 | 623 | 0.080 |
Why?
|
Surface-Active Agents | 1 | 2009 | 152 | 0.080 |
Why?
|
ras Proteins | 1 | 2014 | 1058 | 0.080 |
Why?
|
Karyotyping | 1 | 2010 | 1173 | 0.080 |
Why?
|
Duodenum | 1 | 2012 | 495 | 0.080 |
Why?
|
Cell Cycle | 1 | 2017 | 2942 | 0.080 |
Why?
|
Neoplasm Metastasis | 2 | 2016 | 4931 | 0.080 |
Why?
|
Protein Kinase Inhibitors | 2 | 2022 | 5709 | 0.080 |
Why?
|
Gastritis | 1 | 2010 | 200 | 0.080 |
Why?
|
Organ Preservation | 1 | 2012 | 389 | 0.080 |
Why?
|
Neoplasms, Germ Cell and Embryonal | 1 | 2013 | 495 | 0.080 |
Why?
|
Polymerase Chain Reaction | 2 | 2017 | 6087 | 0.080 |
Why?
|
Antirheumatic Agents | 1 | 2018 | 1374 | 0.080 |
Why?
|
Myocardium | 1 | 2021 | 4789 | 0.080 |
Why?
|
Drug Therapy, Combination | 3 | 2013 | 6320 | 0.070 |
Why?
|
Magnetic Resonance Imaging | 5 | 2014 | 36840 | 0.070 |
Why?
|
Consensus | 3 | 2022 | 3207 | 0.070 |
Why?
|
Promoter Regions, Genetic | 2 | 2016 | 5803 | 0.070 |
Why?
|
Lung Injury | 2 | 2009 | 435 | 0.070 |
Why?
|
Neuroendocrine Tumors | 1 | 2014 | 650 | 0.070 |
Why?
|
Tomography, X-Ray Computed | 6 | 2013 | 20763 | 0.070 |
Why?
|
Hepatectomy | 1 | 2011 | 588 | 0.070 |
Why?
|
Fatty Liver | 2 | 2011 | 807 | 0.070 |
Why?
|
Interferon-alpha | 1 | 2011 | 909 | 0.070 |
Why?
|
Heterozygote | 1 | 2014 | 2792 | 0.070 |
Why?
|
Cell Survival | 1 | 2017 | 5800 | 0.070 |
Why?
|
Cell Cycle Proteins | 1 | 2018 | 3464 | 0.070 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2022 | 5342 | 0.070 |
Why?
|
Sequence Analysis, DNA | 1 | 2017 | 4774 | 0.070 |
Why?
|
Aortic Aneurysm | 1 | 2011 | 649 | 0.070 |
Why?
|
Hematoma | 1 | 2011 | 768 | 0.070 |
Why?
|
Multiprotein Complexes | 1 | 2012 | 1112 | 0.070 |
Why?
|
Mitochondria, Heart | 1 | 2007 | 237 | 0.070 |
Why?
|
Prostatic Hyperplasia | 1 | 2010 | 523 | 0.070 |
Why?
|
Neoplasm Proteins | 1 | 2018 | 3611 | 0.070 |
Why?
|
Child | 6 | 2024 | 80856 | 0.070 |
Why?
|
Intestine, Small | 1 | 2012 | 1218 | 0.060 |
Why?
|
Vocal Cords | 1 | 2010 | 520 | 0.060 |
Why?
|
Pseudomonas aeruginosa | 1 | 2013 | 1277 | 0.060 |
Why?
|
Lymphoma, B-Cell | 1 | 2012 | 945 | 0.060 |
Why?
|
Lower Extremity | 1 | 2013 | 1214 | 0.060 |
Why?
|
Steroids | 1 | 2010 | 937 | 0.060 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2014 | 3550 | 0.060 |
Why?
|
Carcinoma in Situ | 1 | 2011 | 791 | 0.060 |
Why?
|
Aortic Diseases | 1 | 2011 | 742 | 0.060 |
Why?
|
Actins | 1 | 2013 | 2064 | 0.060 |
Why?
|
Proportional Hazards Models | 2 | 2017 | 12561 | 0.060 |
Why?
|
RNA-Binding Proteins | 1 | 2014 | 1885 | 0.060 |
Why?
|
Germ-Line Mutation | 1 | 2013 | 1884 | 0.060 |
Why?
|
Lung Transplantation | 2 | 2012 | 1310 | 0.060 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2012 | 1126 | 0.060 |
Why?
|
Hematopoietic Stem Cells | 1 | 2017 | 3408 | 0.060 |
Why?
|
Drug Resistance | 1 | 2010 | 1599 | 0.060 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2013 | 2048 | 0.060 |
Why?
|
Radiography, Thoracic | 2 | 2021 | 1320 | 0.060 |
Why?
|
Hepacivirus | 1 | 2011 | 1342 | 0.060 |
Why?
|
Rectal Neoplasms | 1 | 2013 | 1179 | 0.060 |
Why?
|
Physical Conditioning, Animal | 1 | 2007 | 366 | 0.060 |
Why?
|
Molecular Targeted Therapy | 1 | 2015 | 2834 | 0.050 |
Why?
|
Radiopharmaceuticals | 1 | 2013 | 2731 | 0.050 |
Why?
|
Hepatitis C, Chronic | 1 | 2011 | 1031 | 0.050 |
Why?
|
Cerebrovascular Disorders | 1 | 2010 | 1487 | 0.050 |
Why?
|
Indazoles | 1 | 2024 | 306 | 0.050 |
Why?
|
Intestines | 1 | 2011 | 1912 | 0.050 |
Why?
|
Ultrasonography | 2 | 2013 | 5994 | 0.050 |
Why?
|
Arthritis, Rheumatoid | 1 | 2018 | 3762 | 0.050 |
Why?
|
Biological Products | 1 | 2012 | 937 | 0.050 |
Why?
|
Anthracyclines | 1 | 2024 | 286 | 0.050 |
Why?
|
Neoplasms, Second Primary | 1 | 2010 | 1062 | 0.050 |
Why?
|
Cardiopulmonary Bypass | 1 | 2007 | 1097 | 0.050 |
Why?
|
Ultrasonography, Prenatal | 1 | 2010 | 1767 | 0.050 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2011 | 1427 | 0.050 |
Why?
|
Colonic Neoplasms | 1 | 2013 | 2544 | 0.050 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2017 | 8636 | 0.050 |
Why?
|
Quality of Life | 1 | 2022 | 13497 | 0.050 |
Why?
|
Genetic Testing | 1 | 2014 | 3586 | 0.040 |
Why?
|
Radiography | 1 | 2011 | 6995 | 0.040 |
Why?
|
Pandemics | 1 | 2020 | 8751 | 0.040 |
Why?
|
Skin Neoplasms | 1 | 2019 | 5891 | 0.040 |
Why?
|
Deoxycytidine | 1 | 2024 | 888 | 0.040 |
Why?
|
Disease Progression | 1 | 2017 | 13643 | 0.040 |
Why?
|
Kidney Diseases | 1 | 2010 | 2102 | 0.040 |
Why?
|
CpG Islands | 2 | 2014 | 1211 | 0.040 |
Why?
|
Receptor, trkA | 1 | 2020 | 159 | 0.040 |
Why?
|
Carrier Proteins | 1 | 2012 | 4948 | 0.040 |
Why?
|
Liver | 2 | 2011 | 7575 | 0.040 |
Why?
|
Antiviral Agents | 1 | 2011 | 3062 | 0.040 |
Why?
|
Anxiety Disorders | 1 | 2010 | 2754 | 0.040 |
Why?
|
Tachycardia | 1 | 2021 | 599 | 0.040 |
Why?
|
Myocytes, Cardiac | 1 | 2007 | 1685 | 0.040 |
Why?
|
Colitis, Ulcerative | 1 | 2010 | 1930 | 0.040 |
Why?
|
Gene Expression Profiling | 1 | 2014 | 9508 | 0.040 |
Why?
|
Histoplasma | 1 | 2018 | 39 | 0.040 |
Why?
|
Animals | 9 | 2022 | 169424 | 0.040 |
Why?
|
Electrocardiography | 2 | 2021 | 6410 | 0.040 |
Why?
|
Postoperative Complications | 3 | 2021 | 15879 | 0.040 |
Why?
|
Immunosuppressive Agents | 1 | 2010 | 4213 | 0.040 |
Why?
|
Gene Fusion | 1 | 2020 | 356 | 0.040 |
Why?
|
Retrospective Studies | 6 | 2024 | 81835 | 0.040 |
Why?
|
Inflammasomes | 1 | 2022 | 541 | 0.040 |
Why?
|
Membrane Proteins | 1 | 2014 | 7895 | 0.040 |
Why?
|
Remission Induction | 2 | 2013 | 2408 | 0.030 |
Why?
|
Interleukin-1beta | 1 | 2022 | 1021 | 0.030 |
Why?
|
Pancreatic Neoplasms | 1 | 2014 | 5443 | 0.030 |
Why?
|
Uric Acid | 1 | 2022 | 808 | 0.030 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2010 | 12242 | 0.030 |
Why?
|
Head and Neck Neoplasms | 1 | 2010 | 2915 | 0.030 |
Why?
|
Histone-Lysine N-Methyltransferase | 1 | 2020 | 697 | 0.030 |
Why?
|
Prevalence | 1 | 2013 | 15879 | 0.030 |
Why?
|
Shock, Cardiogenic | 1 | 2021 | 711 | 0.030 |
Why?
|
Pneumonia | 1 | 2007 | 2162 | 0.030 |
Why?
|
Heart Ventricles | 1 | 2007 | 3839 | 0.030 |
Why?
|
Kidney Transplantation | 1 | 2010 | 4285 | 0.030 |
Why?
|
Microscopy, Electron | 2 | 2008 | 2565 | 0.030 |
Why?
|
Rats, Sprague-Dawley | 3 | 2012 | 8201 | 0.030 |
Why?
|
Sulfonamides | 1 | 2024 | 1988 | 0.030 |
Why?
|
Reactive Oxygen Species | 1 | 2022 | 2150 | 0.030 |
Why?
|
Risk Factors | 3 | 2024 | 74915 | 0.030 |
Why?
|
Echocardiography | 2 | 2021 | 5043 | 0.030 |
Why?
|
Rats | 4 | 2012 | 23839 | 0.030 |
Why?
|
Signal Transduction | 1 | 2017 | 23639 | 0.030 |
Why?
|
Macrophages | 2 | 2023 | 5797 | 0.030 |
Why?
|
Random Allocation | 2 | 2007 | 2399 | 0.030 |
Why?
|
CHARGE Syndrome | 1 | 2012 | 34 | 0.030 |
Why?
|
Colon, Sigmoid | 1 | 2013 | 124 | 0.030 |
Why?
|
Antigens, Differentiation, Myelomonocytic | 1 | 2013 | 283 | 0.030 |
Why?
|
Pyrimidines | 1 | 2024 | 3050 | 0.020 |
Why?
|
Ultrasonography, Doppler, Duplex | 1 | 2013 | 198 | 0.020 |
Why?
|
DNA, Neoplasm | 1 | 2017 | 1749 | 0.020 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 3 | 2024 | 11844 | 0.020 |
Why?
|
Tissue Array Analysis | 1 | 2013 | 551 | 0.020 |
Why?
|
Translocation, Genetic | 1 | 2017 | 1395 | 0.020 |
Why?
|
Capsule Endoscopy | 1 | 2012 | 106 | 0.020 |
Why?
|
gamma-Glutamyltransferase | 1 | 2011 | 144 | 0.020 |
Why?
|
Tomography, Spiral Computed | 1 | 2013 | 274 | 0.020 |
Why?
|
Histocytochemistry | 1 | 2012 | 699 | 0.020 |
Why?
|
Mucositis | 1 | 2011 | 108 | 0.020 |
Why?
|
Epigenesis, Genetic | 2 | 2014 | 3832 | 0.020 |
Why?
|
Hyperplasia | 1 | 2014 | 1154 | 0.020 |
Why?
|
Coronary Artery Disease | 1 | 2010 | 6549 | 0.020 |
Why?
|
Depression | 1 | 2010 | 8235 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2023 | 3939 | 0.020 |
Why?
|
Survival Rate | 2 | 2014 | 12875 | 0.020 |
Why?
|
Blotting, Western | 1 | 2017 | 5042 | 0.020 |
Why?
|
Granulocytes | 1 | 2011 | 550 | 0.020 |
Why?
|
Ribavirin | 1 | 2011 | 395 | 0.020 |
Why?
|
Infant | 1 | 2012 | 36496 | 0.020 |
Why?
|
Infant, Newborn | 1 | 2010 | 26394 | 0.020 |
Why?
|
Tunica Intima | 1 | 2011 | 459 | 0.020 |
Why?
|
Vincristine | 1 | 2011 | 1039 | 0.020 |
Why?
|
Ventricular Fibrillation | 1 | 2011 | 537 | 0.020 |
Why?
|
Alanine Transaminase | 1 | 2011 | 605 | 0.020 |
Why?
|
Citrates | 1 | 2008 | 134 | 0.020 |
Why?
|
Genotype | 2 | 2014 | 13045 | 0.020 |
Why?
|
Immune System | 1 | 2013 | 801 | 0.020 |
Why?
|
Organ Specificity | 1 | 2012 | 1974 | 0.020 |
Why?
|
Obesity | 1 | 2010 | 13065 | 0.020 |
Why?
|
Pregnancy | 1 | 2010 | 30179 | 0.020 |
Why?
|
Volition | 1 | 2007 | 61 | 0.020 |
Why?
|
Rats, Wistar | 1 | 2011 | 1891 | 0.020 |
Why?
|
Chemokines | 1 | 2011 | 963 | 0.020 |
Why?
|
Cloning, Molecular | 1 | 2012 | 4174 | 0.020 |
Why?
|
Prospective Studies | 2 | 2022 | 54913 | 0.020 |
Why?
|
Stroke Volume | 1 | 2021 | 5620 | 0.020 |
Why?
|
Respiratory Function Tests | 1 | 2012 | 1697 | 0.020 |
Why?
|
Protein Transport | 1 | 2012 | 1964 | 0.020 |
Why?
|
Down-Regulation | 1 | 2014 | 2942 | 0.020 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2008 | 699 | 0.020 |
Why?
|
Prednisone | 1 | 2011 | 1568 | 0.020 |
Why?
|
Pulmonary Alveoli | 1 | 2009 | 666 | 0.020 |
Why?
|
HeLa Cells | 1 | 2012 | 3091 | 0.020 |
Why?
|
Blood Vessel Prosthesis | 1 | 2011 | 959 | 0.020 |
Why?
|
Disease Models, Animal | 3 | 2012 | 18390 | 0.020 |
Why?
|
Exons | 1 | 2012 | 2392 | 0.020 |
Why?
|
Ventricular Function | 1 | 2007 | 406 | 0.020 |
Why?
|
Cyclophosphamide | 1 | 2011 | 2224 | 0.020 |
Why?
|
Central Nervous System | 1 | 2012 | 1348 | 0.020 |
Why?
|
Doxorubicin | 1 | 2011 | 2229 | 0.010 |
Why?
|
Survival Analysis | 1 | 2017 | 10127 | 0.010 |
Why?
|
Chest Pain | 1 | 2011 | 1099 | 0.010 |
Why?
|
Mice | 3 | 2022 | 82051 | 0.010 |
Why?
|
Radiotherapy | 1 | 2011 | 1510 | 0.010 |
Why?
|
Perfusion | 1 | 2008 | 1402 | 0.010 |
Why?
|
Aorta | 1 | 2011 | 2046 | 0.010 |
Why?
|
Antigens, CD | 1 | 2013 | 4022 | 0.010 |
Why?
|
Running | 1 | 2007 | 490 | 0.010 |
Why?
|
Societies, Medical | 1 | 2015 | 3954 | 0.010 |
Why?
|
Incidence | 1 | 2021 | 21552 | 0.010 |
Why?
|
Organ Size | 1 | 2007 | 2268 | 0.010 |
Why?
|
Colonoscopy | 1 | 2010 | 1412 | 0.010 |
Why?
|
Transplantation, Homologous | 1 | 2010 | 4834 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2011 | 6527 | 0.010 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2012 | 3612 | 0.010 |
Why?
|
Genome, Human | 1 | 2014 | 4454 | 0.010 |
Why?
|
Patient Selection | 1 | 2013 | 4266 | 0.010 |
Why?
|
Statistics as Topic | 1 | 2007 | 2362 | 0.010 |
Why?
|
Base Sequence | 1 | 2011 | 12426 | 0.010 |
Why?
|
Intestinal Mucosa | 1 | 2011 | 3047 | 0.010 |
Why?
|
Protein Binding | 1 | 2012 | 9376 | 0.010 |
Why?
|
Neurosurgical Procedures | 1 | 2011 | 2096 | 0.010 |
Why?
|
Gene Expression | 1 | 2012 | 7605 | 0.010 |
Why?
|
Ischemia | 1 | 2008 | 1900 | 0.010 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2013 | 3407 | 0.010 |
Why?
|
Recurrence | 1 | 2012 | 8510 | 0.010 |
Why?
|
Imaging, Three-Dimensional | 1 | 2013 | 4077 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2011 | 8559 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2011 | 17637 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2012 | 7602 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2013 | 11249 | 0.010 |
Why?
|
Epithelial Cells | 1 | 2009 | 3697 | 0.010 |
Why?
|
Sepsis | 1 | 2011 | 2602 | 0.010 |
Why?
|
Swine | 1 | 2007 | 5996 | 0.010 |
Why?
|
Positron-Emission Tomography | 1 | 2013 | 6657 | 0.010 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2007 | 4362 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2013 | 20232 | 0.010 |
Why?
|
Age Factors | 1 | 2011 | 18477 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2011 | 10269 | 0.010 |
Why?
|
Inflammation | 1 | 2014 | 10863 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2011 | 16023 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2007 | 22365 | 0.000 |
Why?
|